/b/veterinary-news/posts/ceva-launches-prilactone-174-to-combat-canine-heart-disease Prilactone®, the world’s first aldosterone antagonist licensed for the treatment of canine heart disease, has been introduced by CEVA Animal Health. Clinical trials have demonstrated that the product, which contains spironolactone, can improveen-USTelligent Community 10